Check out our all-new JDD Video Abstract from Naiem T. Issa, MD, PhD, who discusses how new formulations of acyclothymidine dinucleosides reduces the damaging effects of ultraviolet radiation in an…
JDD Spotlight: Dupilumab Shows Rapid, Sustained Relief for Lichenification in AD A new pooled analysis from five clinical trials has revealed that dupilumab significantly improves lichenification in moderate to severe…
JDD Spotlight The PROAK study evaluated real-world outcomes in patients with actinic keratosis reated with tirbanibulin 1% ointment over 24 weeks. Early improvements in quality of life were noted as…
From the Vault Do collagen supplements really work for skin? Collagen supplements are booming in the skincare world, but do they truly deliver on their promises? With little regulation around…
Trending Article Alert Integrated skincare—the future of aesthetic outcomes? A roundtable, featured at the Thriving in Diversity webinar series, brought together leading dermatologists and cosmetic surgeons to discuss how integrated…
Did You Miss It? How does the roflumilast cream vehicle compare? For patients with inflammatory dermatologic conditions, a hydrating vehicle is key to improving the skin barrier without irritation. But…
From the Vault Isotretinoin remains the gold standard for treating severe nodulocystic acne, yet concerns about its potential psychiatric effects continue to spark debate. While high-quality studies have found no…
Featured Podcast Managing alopecia is already anxiety provoking enough, but throw some inflammatory scalp diseases into the mix...ok deep breaths...think of a happy place. So happy your brain brought you…
Featured Article Acanthosis nigricans disproportionately affects individuals with darker skin tones, yet no FDA-approved treatment currently exists. As the demand for effective therapies grows, the dermatology community faces a critical challenge:…
Check out our all-new JDD Video Abstract from Zoe Diana Draelos, MD, who assesses the vehicle for roflumilast cream compared to a ceramide-containing moisturizing cream in treating mild eczema.
Featured Article Have you missed this November 2024 article that's been making headlines? GLP-1 receptor agonists (GLP1RAs), including liraglutide and semaglutide, are proving effective beyond their established roles in weight…
Featured Article Who is at risk for hypertrophic scars and keloids? A study of 6,249 patients reveals that hypertrophic scars and keloids are significantly more common in Black/African American individuals…